— Know what they know.
Not Investment Advice

GMDA NASDAQ

Gamida Cell Ltd.
1W: +111.0% 1M: +116.6% 3M: -91.2% 1Y: -98.0% 3Y: -99.5% 5Y: -99.5%
$0.03
Last traded 2025-06-17 — delisted
NASDAQ · Healthcare · Biotechnology · $4.3M mcap · 120M float · 18.03% daily turnover

Income Trends

Revenue
$2M +0.0% ▲
Gross Profit
-$2M -285.0% ▼
Operating Income
-$73M -197.4% ▼
Net Income
-$63M +59.2% ▲
EPS (Diluted)
$-0.57 +76.4% ▲
EBITDA
-$53M +5.3% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
Revenue$0$0$0$0$2M
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$2M$357K$431K$440K$3M
Gross Profit-$2M-$357K-$431K-$440K-$2M
Gross Margin————-95.0%
R&D Expenses$31M$41M$50M$43M$22M
SG&A Expenses$12M$12M$17M$19M$49M
Operating Expenses$48M$62M$87M$75M$71M
Operating Income-$48M-$62M-$87M$75M-$73M
Operating Margin————-4094.1%
Interest Expense$3M$11M$3M$4M$8M
Income Before Tax-$34M-$73M-$90M-$79M-$63M
Tax Expense-$70K$4M$0$0$0
Net Income-$34M-$76M-$92M-$154M-$63M
Net Margin————-3531.2%
EPS (Diluted)$-1.16$-1.75$-1.56$-2.42$-0.57
EBITDA-$29M-$61M-$87M-$75M-$53M
Shares Outstanding30M44M59M64M149M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms